Integra LifeSciences Holdings Management
Management criteria checks 4/4
Integra LifeSciences Holdings' CEO is Jan De Witte, appointed in Dec 2021, has a tenure of 2.92 years. total yearly compensation is $6.39M, comprised of 13.7% salary and 86.3% bonuses, including company stock and options. directly owns 0.031% of the company’s shares, worth $579.46K. The average tenure of the management team and the board of directors is 3.6 years and 11.5 years respectively.
Key information
Jan De Witte
Chief executive officer
US$6.4m
Total compensation
| CEO salary percentage | 13.7% |
| CEO tenure | 2.9yrs |
| CEO ownership | 0.03% |
| Management average tenure | 3.6yrs |
| Board average tenure | 11.5yrs |
Recent management updates
Recent updates
There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise
Nov 05
Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Oct 24Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S
Sep 08Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?
Aug 21At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?
Jul 01Integra LifeSciences Still Underperforming As Manufacturing Issues Linger
Jun 21Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price
May 28Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled
Feb 27We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jan 14Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings
Dec 31Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?
Dec 03Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns
Oct 24Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 22Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?
Aug 15Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes
Jul 03Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jun 19Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
May 05These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital
Mar 26At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?
Mar 14Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?
Feb 27Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Feb 02We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return
Dec 21When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Dec 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$7m |
| Jun 30 2024 | n/a | n/a | US$24m |
| Mar 31 2024 | n/a | n/a | US$40m |
| Dec 31 2023 | US$6m | US$875k | US$68m |
| Sep 30 2023 | n/a | n/a | US$101m |
| Jun 30 2023 | n/a | n/a | US$131m |
| Mar 31 2023 | n/a | n/a | US$172m |
| Dec 31 2022 | US$9m | US$850k | US$181m |
| Sep 30 2022 | n/a | n/a | US$173m |
| Jun 30 2022 | n/a | n/a | US$166m |
| Mar 31 2022 | n/a | n/a | US$157m |
| Dec 31 2021 | US$899k | US$59k | US$169m |
Compensation vs Market: Jan's total compensation ($USD6.39M) is about average for companies of similar size in the US market ($USD5.54M).
Compensation vs Earnings: Jan's compensation has been consistent with company performance over the past year.
CEO
Jan De Witte (60 yo)
2.9yrs
Tenure
US$6,388,756
Compensation
Mr. Jan De Witte has been President, Chief Executive Officer & Director of Integra LifeSciences Holdings Corporation since December 1, 2021. He had been the Chief Executive Officer at Barco NV since Septem...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 26.9yrs | US$422.52k | 2.27% $ 42.5m | |
| President | 2.9yrs | US$6.39m | 0.031% $ 579.5k | |
| Executive VP & CFO | 1.4yrs | US$1.67m | 0.054% $ 1.0m | |
| Senior VP of Finance & Principal Accounting Officer | 7.1yrs | US$1.25m | 0.047% $ 874.8k | |
| Executive VP | 6yrs | US$1.62m | 0.082% $ 1.5m | |
| Executive VP & President of Tissue Technologies | 11.9yrs | US$1.42m | 0.084% $ 1.6m | |
| Executive VP & President of Codman Specialty Surgical | 4.5yrs | US$2.83m | 0.075% $ 1.4m | |
| Corporate VP of Global Operations & Supply Chain | 4.3yrs | no data | no data | |
| Vice President of Global Corporate Communications & Public Relations | no data | no data | no data | |
| Vice President of Global Marketing | no data | no data | no data | |
| Executive VP & Chief Human Resources Officer | 1.8yrs | no data | 0.032% $ 590.9k | |
| Corporate VP & Chief Digital Officer | 2.8yrs | no data | no data |
3.6yrs
Average Tenure
57yo
Average Age
Experienced Management: IART's management team is considered experienced (3.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 26.9yrs | US$422.52k | 2.27% $ 42.5m | |
| President | 2.9yrs | US$6.39m | 0.031% $ 579.5k | |
| Independent Director | 15.6yrs | US$297.54k | 0.11% $ 2.0m | |
| Independent Director | 18.8yrs | US$293.28k | 0.082% $ 1.5m | |
| Independent Presiding Director | 11.5yrs | US$342.54k | 0.18% $ 3.3m | |
| Independent Director | 32.8yrs | US$306.31k | 0.091% $ 1.7m | |
| Independent Director | less than a year | US$90.68k | 0.016% $ 302.8k | |
| Independent Director | 3.6yrs | US$260.04k | 0.028% $ 531.4k | |
| Independent Director | 2.3yrs | US$297.54k | 0.021% $ 391.5k |
11.5yrs
Average Tenure
63yo
Average Age
Experienced Board: IART's board of directors are seasoned and experienced ( 11.5 years average tenure).